Kruk SA (KRU)
Warsaw Stock Exchange · Poland · prices in PLN · close of 22 Oct 2026
Key indicators
| Last close | PLN 354.20 |
|---|---|
| 52-week range | 334.20 – 510.00 |
| Return, 1 month / 3 months | −10.1% / −15.5% |
| Return, 1 year / 3 years | −17.7% / −11.8% |
| Trend | Below its 200-day average |
| RSI (14) | 42 |
| Volatility (1 year) | 27.7% |
| Worst drawdown (1 year) | -30.0% |
| Average daily value traded | 24.57M PLN |
| Dividend yield | 5.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Kruk SA is a debt management company based in Wrocław, Poland. It buys portfolios of unpaid debts, mainly consumer and corporate receivables, from banks and other creditors, and then works with borrowers to recover the money through payment plans and other arrangements. The company also offers debt collection services on behalf of financial institutions. Its customers are lenders and businesses holding overdue accounts, and its operations extend across several European markets.
The shares are listed on the Warsaw Stock Exchange in Poland under the code KRU, and the price on this page is in Polish zloty (PLN). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Kruk SA (KRU) trades on the Warsaw Stock Exchange in Poland. It last closed at PLN 354.20 on 22 October 2026.
Its price-based Market X-Ray is 52 out of 100 (a fair price profile), ranking 285 of 580 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 17.7% and over the last three months it fell 15.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Warsaw Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 28 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -15.7% | ||
| From 52-week high | -29.8% | ||
| Momentum | 25 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -15.5% | ||
| 6-month return | -23.9% | ||
| 12-month return, skipping the last month | -8.4% | ||
| Stability (higher is calmer) | 70 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 27.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -30.0% | ||
| Liquidity | 96 · Strong | Trades actively. | |
| Average daily value traded | 24.57M PLN | ||
| Zero-volume days | 0.0% | ||
| Income | 65 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.6% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +2.9% |
|---|---|
| 1 month | −10.1% |
| 3 months | −15.5% |
| 6 months | −23.9% |
| 1 year | −17.7% |
| 3 years | −11.8% |
| 5 years | +30.6% |
Signals
| 50-day / 200-day average | 387.31 / 420.41 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 10.65 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 May 2026 | PLN 20.0000 |
| 9 Jul 2025 | PLN 18.0000 |
| 14 May 2024 | PLN 18.0000 |
| 6 Sep 2023 | PLN 15.0000 |
| 20 Apr 2022 | PLN 13.0000 |
| 23 Jun 2021 | PLN 11.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Warsaw Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.